UNSPSC 51422214: Triamcinolone benetonide

This classification denotes a therapeutic glucocorticoid C35H42FNO8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9DXL8A82MI, chemically known as 9-fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone 21-ester with n-benzoyl-2-methyl-.beta.-alanine, but more generally known as triamcinolone benetonide, which bears US NIH Compound Identifier 62963.

UNSPSC 51422214 Triamcinolone benetonide is a Commodity code that in recent state and local procurement activity does not reflect purchases of the pharmaceutical corticosteroid named in the code taxonomy. The single recent opportunity tagged to this code — Seminole County, Florida's IFB60459723LAS — solicits naloxone and safe drug deactivation systems, products unrelated to triamcinolone benetonide. State and local governments appear to buy triamcinolone benetonide, if at all under this code, through channels not yet reflected in current solicitation activity, or the code may be misapplied in issuing systems to unrelated opioid-response and harm-reduction products.

Seminole County, Florida posted IFB60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB closed July 26, 2023, and included requirements for drug-free workplace certification, E-Verify compliance, and specific insurance coverage. The contract term is two years with an optional one-year renewal, potentially funded through FEMA. This opportunity reflects a mismatch between the code's intended pharmaceutical scope and the actual goods being solicited; buyers pursuing this code should verify current tagging practices with individual issuing offices before committing resources.